Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(24 sites)
United States
Saguaro Dermatology, Phoenix, Arizona First Oc Dermatology, Fountain Valley, California Amicis Research Center Valencia, Northridge, California Children'S Hospital of Orange County, Orange, California Clinical Trials Research Institute, Thousand Oaks, California Clarity Dermatology, Castle Rock, Colorado Advanced Pharma Cr, Llc, Miami, Florida Advanced Pharma Cr, Llc, Miami, Florida International Clinical Research Tennessee Llc, Sanford, Florida Lenus Research Medical Group, Llc, Sweetwater, Florida Trueblue Clinical Research, Tampa, Florida Lane Dermatology and Dermatologic Surgery, Columbus, Georgia Options Research Group, Llc, West Lafayette, Indiana Equity Medical, Llc, Bowling Green, Kentucky Delricht Research, Baton Rouge, Louisiana Revival Research Institute, Llc Troy, Troy, Michigan Red River Research Partners, Bolivar, Missouri Dr Bobby Buka, Md Greenwich Village, New York, New York Equity Medical, Llc, New York, New York Red River Research Partners, Fargo, North Dakota Centricity Research Columbus, Columbus, Ohio Unity Clinical Research, Oklahoma City, Oklahoma Paddington Testing Co Inc, Philadelphia, Pennsylvania Dermresearch, Inc., Austin, Texas